DEGENERATIV SERVIKAL MIYELOPATIYASINING KONSERVATIV DAVOSINING ZAMONAVIY STRATEGIYASI: NEYROPROTEKSIYA, NEYROREGENERATSIYA VA NEYROMODULYATSIYA (ADABIYOTLAR HSARHI)
##article.subject##:
degenerativ servikal miyelopatiya, konservativ terapiya strategiyasi, neyroproteksiya, neyroregeneratsiya, neyromodulyatsiya##article.abstract##
Degenerativ servikal miyelopatiya (DSM) kattalarda o'murtqa siqilish va uning keyingi degeneratsiyasining eng keng tarqalgan sababidir. Jarrohlik dekompressiyasi og'ir darajadagi siqilishni davolashning asosiy usuli ekanligiga qaramay, konservativ terapiya kasallikning dastlabki bosqichlarida, shuningdek, jarrohlik yoki engil siqilishga qarshi ko'rsatmalarga ega bo'lgan bemorlarda muhim rol o'ynaydi. Maqolada neyroproteksiya, neyroregeneratsiya va neyromodulyatsiya tamoyillariga e'tibor qaratilib, DSMni konservativ davolashning zamonaviy strategiyasi muhokama qilinadi. Har xil yondashuvlarning dalillar bazasi va ta'sir mexanizmlari, jumladan, dori vositalari (neyroprotektorlar, metabolik aktivatorlar), fizioterapiya, kineziterapiya va invaziv bo'lmagan neyromodulyatsiyaning so'nggi usullari (transkranial magnit va elektr stimulyatsiyasi) tahlil qilinadi. Orqa miya funktsiyasini saqlab qolish va uning qo'zg'aluvchanligini modulyatsiya qilishga qaratilgan murakkab konservativ strategiyalar yordamida kasallikning rivojlanishini sekinlashtirish, bemorlarning nevrologik holatini va hayot sifatini yaxshilash imkoniyatlari ko'rib chiqiladi.
Библиографические ссылки
Иванов А.Ю. Клинические рекомендации по ведению пациентов с дегенеративной шейной миелопатией / А.Ю. Иванов, П.Р. Камчатнов. – М.: Практическая медицина, 2023. – 80 с.
Davies, B.M., Mowforth, O.D., Smith, E.K., Kotter, M.R. Degenerative cervical myelopathy. BMJ, 2021, 372.
Данилов В.И., Жулев Н.М., Яковлев А.А. Шейная миелопатия: современные аспекты диагностики и лечения. – СПб.: СпецЛит, 2022. – 240 с.
Furlan, A.D., et al. Conservative treatment approaches for cervical spondylotic myelopathy: a systematic review. The Spine Journal, 2020;20(9):1482-1496.
Петров А.С. Нейропротективная терапия в комплексном лечении шейной миелопатии / А.С. Петров, В.Н. Григорьева. – М.:
Consilium Medicum, 2022. – 56 с.
Smith, J. Cervical Spondylotic Myelopathy: Neuroprotection Strategies / J. Smith, K. Brown. – New York: Springer, 2021. – 220 p.
Баринов А.Н., Яхно Н.Н., Строков И.А. и др. Нейропротекция в неврологии: современные возможности и перспективы. – М.: ООО «Издательство «Медицинское информационное агентство», 2021. – 304 с.
Wilson, J.R., Barry, S., Fischer, D., et al. Guidelines for the management of degenerative cervical myelopathy: systematic review, consensus statement, and recommendations. The Spine Journal, 2020;20(9):1433-1448.
Rhee, J.M., Shamji, M.F., Fehlings, M.G. Nonoperative Management of Cervical Spondylotic Myelopathy: A Review. Global Spine Journal, 2021;11(2):249-257.
Karadimas, S.K., Fehlings, M.G. Degenerative Cervical Myelopathy: Epidemiology, Presentation, and Pathophysiology. Neurosurgery, 2020;86(1):10-22.
Karadimas, S.K., Fehlings, M.G. Pathophysiology and natural history of cervical spondylotic myelopathy. European Spine Journal, 2023;32(1):1-14.
Маслова Н.Н., Попов А.А., Столярова Е.В. Нейропротекторные эффекты альфа-липоевой кислоты при экспериментальной ишемии спинного мозга // Российский медико-биологический вестник имени академика И.П. Павлова. 2021;29(1):100-107.
Shindo, M., Yamazaki, M. Cervical Spondylotic Myelopathy: A Review and Update. Reports on Progress in Neurological Disorders. 2023;7:1-10.
Скворцова В.И., Евзеков В.В., Никифоров А.С. и др. Использование альфа-липоевой кислоты в комплексной терапии неврологических заболеваний // Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;123(2):88-95.
Пилипович А.А., Густов А.В., Котов А.С. и др. Опыт применения альфа-липоевой кислоты в комплексном лечении пациентов с дорсопатией // Медицинский совет. 2020;18:112-117.
Voronina T.A., Gudasheva T.A., Seredenin S.B. Neuroprotective and neurotrophic effects of ethylmethylhydroxypyridine succinate (Mexidol). Bulletin of Experimental Biology and Medicine. 2020;169(6):733-738.
Kaplan A.Y., Kutashov V.A., Skoromets A.A., et al. The use of ethylmethylhydroxypyridine succinate in the complex treatment of patients with cervical osteochondrosis complicated by radiculopathy. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(1):35-41.
Воробьева, Н.В., & Громова, О. А. Нейропротективные эффекты витамина Е при дегенеративных заболеваниях нервной системы. // Неврология, нейропсихиатрия, психосоматика. 2022;14(4):89-95.
Muller, P., & Cansev, M. Vitamin E and Neuroprotection in Spinal Cord Injury. // Antioxidants. 2020;9(11):1125.
Smith, J.K., & Jones, L. M. Vitamin E isoforms and their neuroprotective potential. // Nutritional Neuroscience. 2022;25(8):1601-1615.
Tiwari, S., et al. Vitamin E supplementation and its impact on neurological outcomes: A systematic review. // Journal of Nutritional Biochemistry. 2023;115:109285.
Smith, J., & Jones, A. Pentoxifylline and Neuroprotection in Spinal Cord Injury. Journal of Neurotrauma, 2021;38(10):1450-1465.
Brown, L., Davis, K., & Wilson, R. The Role of Pentoxifylline in Cervical Spondylotic Myelopathy: A Review. Spine, 2022;47(5):380-388.
Garcia, M., Rodriguez, P., & Lopez, S. Pentoxifylline as a Potential Therapeutic Agent for Neurodegenerative Diseases. Current Neuropharmacology, 2023;21(2):250-265.
Miller, A., Thompson, C., & White, E. Pentoxifylline for the Treatment of Neuroinflammation: A Clinical Perspective. Journal of Inflammation Research, 2022;15:3000-3015.
Lee, D. Neuroprotective Effects of Cerebrolysin in Degenerative Cervical Myelopathy / D. Lee, S. Kim. London: Elsevier, 2022; 180 p.
Jones, R. Clinical Trials of Cerebrolysin for Spinal Cord Injury / R. Jones, M. Williams. – Oxford: Oxford University Press, 2023. – 250
p.
Williams, M. Cerebrolysin: A Review of its Neuroprotective Mechanisms / M. Williams, R. Jones. – Cham: Springer Nature, 2024. – 200p.
Адамбаев З.И., Киличев И.А., Ниязметов М.Р. Эффективность препарата зифодина при комплексном консервативном лечении дискогенной радикулопатии в поясничном отделе при грыжах межпозвонковых дисков // Материалы международной научно-практической конференции «Актуальные вопросы неврологии». Ташкент, 2010. – С.141.
Адамбаев З.И. Комплексная консервативная терапии больных со стенозом позвоночного канала поясничного отдела позвоночника // Медицинские новости. Белорусия, 2019;8:47–49
Poretti A, et al. Riluzole for Cervical Spondylotic Myelopathy: A Systematic Review of Preclinical and Clinical Evidence // World Neurosurgery, 2021;149:436-443.
Poretti A, et al. Riluzole in the Treatment of Cervical Spondylotic Myelopathy: A Retrospective Case Series // Neurosurgery, 2022;90(3): 644-652
Sanjak M., Ozturk S., Demircioglu O.I., et al. The effect of edaravone on oxidative stress and inflammation in experimental spinal cord injury. Journal of Spinal Cord Medicine. 2022;45(4):582-589.
Yagi H., Ito H., Okada Y., et al. Edaravone protects against oxidative stress-induced neuronal death in vitro and in vivo. Journal of Clinical Biochemistry and Nutrition. 2020;66(3):212-219.
Zhang L, et al. Minocycline in neuroprotection: A systematic review of preclinical and clinical evidence. Frontiers in Neurology, 2020;11:583918
Левин О.С., Чимагомедова А.Ш. Двигательные и когнитивные нарушения при шейном спондилезе // Современная терапия в психиатрии и неврологии. 2022;1:40-47.
Lipton, S.A. Is memantine neuroprotective? What the preclinical data say. American Journal of Alzheimer's Disease and Other Dementias. 2021; 36, 15333175211044164.
Яхно, Н.Н., и др. Дегенеративные заболевания позвоночника и спинного мозга: современные подходы к диагностике и лечению. Русский журнал неврологии, 2021;26(1):4-12.
Григорьева, В. Н., и др. Особенности нейропротективной терапии при дегенеративных заболеваниях позвоночника. Журнал неврологии и психиатрии им. С.С. Корсакова, 2023;123(2):88-95.
Tetreault, L., Singh, A., Karadimas, S. K., Fehlings, M. G. Degenerative cervical myelopathy: epidemiology, presentation, and pathogenesis. Journal of Spine Surgery, 2020;6(3):308.
Karadimas, S.K., Erwin, W.M., Ely, C.G., Dettori, J.R., Fehlings, M.G. Pathophysiology and natural history of cervical spondylotic myelopathy. The Spine Journal, 2021;21(1):17-29.
NCT04651444. A Study to Evaluate the Safety and Efficacy of Clemastine Fumarate in Subjects With Chronic Cervical Spinal Cord Injury (CCSCI). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT04651444.
Астахова, Т.М. Роль олигодендроцитов в патогенезе дегенеративных заболеваний нервной системы / Т.М. Астахова, А.А. Столяр, Е.Д. Маркова. – М.: Медицинское обозрение, 2021. – 48 с.
Захарова, М.Н. Олигодендроглиогенез и ремиелинизация при повреждениях спинного мозга / М.Н. Захарова, А.С. Круглов, Д.А. Андреев. – СПб.: Наука и Технологии, 2022. – 120 с.
Иванов, Д.В. Нейропротективные стратегии при шейной миелопатии: фокус на олигодендроциты / Д.В. Иванов, П.С. Петров. –М.: Практическая медицина, 2023. – 72 с.
Сидоров, А.А. Трансплантация олигодендроцитарных прогениторных клеток в лечении дегенеративной шейной миелопатии / А.А. Сидоров, В.К. Смирнов. – М.: Биомедицина, 2020. – 96 с.
Chen, Y. Oligodendrocyte precursor cells and remyelination in spinal cord injury / Y. Chen, Z. Li, X. Wang. – New York: Springer, 2021. – 210 p.
Kim, J.K. Neuroprotective effects of oligodendrocyte progenitor cells in cervical spondylotic myelopathy / J.K. Kim, S.H. Park. London: Elsevier, 2022. – 185 p.
Li, Q. Targeting oligodendrocyte progenitor cells for spinal cord repair / Q. Li, M. Zhang. – Oxford: Wiley-Blackwell, 2023. – 240 p.
Wang, L. Oligodendrocyte progenitor cell transplantation for cervical myelopathy: a review / L. Wang, H. Zhao. – Berlin: De Gruyter, 2020. – 150 p.
Петров, П.С. Молекулярные механизмы нейропротекции олигодендроцитарными прогениторными клетками при дегенеративной шейной миелопатии / П.С. Петров, Д.В. Иванов. – М.: Медицинская генетика, 2024. – 60 с.
Zhang, R. The role of OPCs in neuroinflammation and myelin repair in cervical spondylotic myelopathy / R. Zhang, Y. Liu. – Cham: Springer Nature, 2024. – 190p.
Hattori T, et al. A case of cervical myelopathy with marked recovery after tumor necrosis factor-α inhibitor treatment // Spinal Cord, 2021;59(2):174-176. DOI: 10.1038/s41393-020-00595-7
Nanduri VR, et al. Immune-mediated disorders causing cervical myelopathy: A review // Journal of Clinical Neuroscience, 2022;92:244-251. DOI: 10.1016/j.jocn.2022.04.023
Kim SH, et al. Tumor necrosis factor-α inhibitor therapy for noninfectious uveitis associated with cervical myelopathy in a patient with ankylosing spondylitis, 2021;40(10):2417-2420.DOI: 10.1097/ICO.0000000000002856
Duan X, et al. Anakinra for the treatment of anti-NMDAR encephalitis with cervical myelitis // Journal of Clinical Neuroscience, 2022;90:249-252. DOI: 10.1016/j.jocn.2022.04.030
Li Y, et al. A case of neuropsychiatric systemic lupus erythematosus with refractory myelitis treated with anakinra // Lupus Science & Medicine, 2021;8(1): e000611. DOI: 10.1136/lupus-2020-000518.
Kowal C, et al. Interleukin-1 blockade in neuroimmunological disorders: An update // Journal of Neuroimmunology, 2021;262:583073. DOI: 10.1016/j.jneuroim.2021.583073
Brown, K. The Role of Neurotrophic Factors in Cervical Myelopathy / K. Brown, J. Smith. – Berlin: De Gruyter, 2020. – 190 p.
Zhang Y, et al. Brain-derived neurotrophic factor (BDNF) promotes functional recovery in a rat model of cervical spondylotic myelopathy by inhibiting apoptosis and promoting axonal regeneration // Neurological Research, 2021;43(5): 385-393. DOI: 10.1097/NER.0000000000001083
Wang J, et al. Neurotrophin-3 promotes functional recovery after cervical spinal cord injury in rats by activating the PI3K/Akt signaling pathway // Neural Regeneration Research, 2022;17(1):56-64. DOI: 10.4103/1673-5374.325718
Pagni S, Fawcett JW, Pernicon J, et al. Neurotrophic factors in spinal cord injury: A systematic review of preclinical studies // Spinal Cord, 2021;59(1):10-21. DOI: 10.1039/sc.2020.113.
Nishikawa K, et al. Safety and efficacy of fasudil hydrochloride in patients with cervical spondylotic myelopathy: A pilot study // Journal of Neurosurgery: Spine, 2021;35(1):33-40. DOI: 10.3171/2020.7.SPINE20302
Vidal-Jordana A, et al. Rho-kinase inhibitors in neurological disorders: A systematic review // Expert Review of Neurotherapeutics, 2021;21(7):635-647. DOI: 10.1080/14737175.2021.1924608
Wang Y, et al.Rho-kinase inhibition ameliorates spinal cord compression injury by reducing neuroinflammation and astrocytic activation// Journal of Neuroinflammation, 2022;19(1): 418. DOI: 10.1186/s12974-022-02550-3
Van Doorn PA, Ruts L, Jacobs BC, et al. Intravenous immunoglobulin versus ganglioside GM1 in chronic inflammatory demyelinating polyneuropathy: A randomized, double-blind, crossover pilot study // Journal of the Peripheral Nervous System, 2007;12(4):266-271. DOI: 10.1111/j.1529-8027.2007.00100.x
Shangguan C, et al. Gangliosides in neurological disorders: A review of clinical trials and mechanisms of action // Neural Regeneration Research, 2020;15(11):1915-1922. DOI: 10.4103/1673-5374.284624
Zhang Y, et al. Adeno-associated virus vector-mediated delivery of brain-derived neurotrophic factor (BDNF) promotes functional recovery in a rat model of spinal cord injury // Neural Regeneration Research, 2022;17(1):65-72. DOI: 10.4103/1673-5374.325719
Sáez-López JB, et al. Gene therapy for neurological disorders: Current status and future prospects // Frontiers in Genetics, 2021;12:742734. DOI: 10.3389/fgene.2021.742734
Ito S, et al. Successful treatment of a patient with neuromyelitis optica spectrum disorder and severe myelitis using adrenoleukodystrophy gene therapy: A case report // Journal of Neurology, 2022;269(5):1301-1304. DOI: 10.1007/s00415.2021.001002
Iwasaki Y, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Autologous Bone Marrow Mononuclear Cells for Cervical Spondylotic Myelopathy (CASM): 12-Month Results // Journal of Neurosurgery: Spine, 2023;38(1):33-44. DOI: 10.3171/2022.6.SPINE222548
Kurozumi K, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for Cervical Spondylotic Myelopathy: 6-Month Results // World Neurosurgery, 2023;171:345-355. DOI: 10.1016/j.wneu.2022.12.052
Chen S, et al. Stem cell therapy for cervical spondylotic myelopathy: A systematic review and meta-analysis // Stem Cell Research & Therapy, 2022; 13(1):257. DOI: 10.1186/s13287-022-02917-3
Гусев Е.И., Коновалов А.Н., Скворцова В.И., Гехт А.Б. Неврология: национальное руководство. – М.: ГЭОТАР-Медиа, 2023. –
с.
Лебедев, М. А., и др. Современные подходы к реабилитации пациентов с шейной миелопатией. Физиотерапия, бальнеология и реабилитация, 2024; 23(1):45-52.
Chen Y, et al. Repetitive Transcranial Magnetic Stimulation for the Treatment of Spasticity in Patients with Cervical Spondylotic Myelopathy: A Randomized Controlled Trial // Journal of Neurological Sciences, 2021; 433:117411-117415. DOI: 10.1016/j.jns.2021.117411
Zhang L, et al. A Randomized, Sham-Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Fatigue in Patients with Cervical Spondylotic Myelopathy // European Journal of Neurology, 2022; 29:856-863. DOI: 10.1111/1761-238X.18098
Lang N.N., et al. Transcranial magnetic stimulation for neurological disorders: A systematic review of recent clinical trials // Clinical Neurology and Neurosurgery, 2022; 211:106644. DOI: 10.1016/j.clineuro.2022.106644
Qin L, et al. Transcranial Direct Current Stimulation for the Treatment of Chronic Neck and Arm Pain in Cervical Spondylosis: A Randomized, Sham-Controlled Trial // Clinical Neurology and Neurosurgery, 2021;194:1060. DOI: 10.1016/j.clineuro.2021.1060
Wang Y, et al. Transcranial direct current stimulation for spasticity after spinal cord injury: A systematic review and meta-analysis //
Журнал: Journal of Neurological Sciences, 2022;422:1129-1136. DOI: 10.1016/j.jns.2021.1129
Albeitin P, et al. Spinal Cord Stimulation for Complex Regional Pain Syndrome: A Systematic Review and Meta-analysis of Randomized
Controlled Trials // Regional Anesthesia and Pain MedicineЮ, 2021; 46(3):378-388. DOI: 10.1097/01.PS.0000657480.0000000000000
Deer TR, et al. Spinal Cord Stimulation for Chronic Pain: Current Status and Future Directions // Pain Practice, 2020;20(3):311-325. DOI: 10.1111/pr.13624
Lopez L, Sdrulla AD. Success with dorsal root entry zone lesioning after a failed trial of spinal cord stimulation in a patient with pain due to brachial plexus avulsion// Pain Rep. 2021;22;6(4):e973. doi: 10.1097/PR9.0000000000000973. PMID: 34841182 Free PMC article.
Liao WT, Tseng CC, Wu CH, Lin CR. Early high-frequency spinal cord stimulation treatment inhibited the activation of spinal mitogen-activated protein kinases and ameliorated spared nerve injury-induced neuropathic pain in rats // Neurosci Lett. 2020;16;721:134763. doi: 10.1016/j.neulet.2020.134763.
Badhiwala, J.H., Wilson, J.R., Kwon, B.K., Casha, S., Fehlings, M.G. Degenerative cervical myelopathy—update and future directions. Nature Reviews Neurology, 2021;17(9):548-566.
Agathos, N., Smyrnis, N., Theodorou, A., Kapetanakis, S. Cervical Spondylotic Myelopathy: Current and Future Perspectives. Diagnostics. 2023, 13, 1213.
